Identification of extractable growth factors from small intestinal submucosa

When implanted as a biomaterial for tissue replacement, selected submucosal layers of porcine small intestine induce site‐specific tissue remodeling. Small intestinal submucosa (SIS), as isolated, is primarily an acellular extracellular matrix material. In an attempt to discover the components of small intestinal submucosa which are able to induce this tissue remodeling, the material was extracted and extracts were tested for the ability to stimulate Swiss 3T3 fibroblasts to synthesize DNA and proliferate. Each of the four different extracts of small intestinal submucosa had measurable cell‐stimulating activity when analyzed in both a whole cell proliferation assay (alamarBlue dye reduction) and a DNA synthesis assay ([3H]‐thymidine incorporation). Proteins extracted from SIS with 2 M urea induced activity profiles in the two assays which were very similar to the activity profiles of basic fibroblast growth factor (FGF‐2) in the assays. As well, the changes in cell morphology in response to the extracted proteins mimicked the changes induced by FGF‐2. Neutralization experiments with specific antibodies to this growth factor confirmed the presence of FGF‐2 and indicated that it was responsible for 60% of the fibroblast‐stimulating activity of the urea extract of small intestinal submucosa. Western blot analysis with a monoclonal antibody specific for FGF‐2 detected a reactive doublet at approximately 19 kDa and further confirmed the presence of FGF‐2. Cell stimulating activity of proteins extracted from SIS with 4 M guanidine was neutralized by an antibody specific for transforming growth factor β (TGFβ). Changes in the morphology of the fibroblasts exposed to this extract were nearly identical to changes induced by TGFβ. Although no reactive protein band was detected at 25 kDa in nonreduced western blot analysis, several bands were reactive at higher molecular weight. The identity of this TGFβ‐related component of small intestinal submucosa is unknown. Identification of FGF‐2 and TGFβ‐related activities in SIS, two growth factors known to significantly affect critical processes of tissue development and differentiation, provides the opportunity to further elucidate the mechanisms by which this extracellular matrix biomaterial modulates wound healing and tissue remodeling. J. Cell. Biochem. 67:478–491, 1997. © 1997 Wiley‐Liss, Inc.

[1]  A. Burgess,et al.  The major colonic cell mitogen extractable from colonic mucosa is an N terminally extended form of basic fibroblast growth factor. , 1991, The Journal of biological chemistry.

[2]  M J Banda,et al.  Large induction of keratinocyte growth factor expression in the dermis during wound healing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R Langer,et al.  Tissue engineering: biomedical applications. , 1995, Tissue engineering.

[4]  Thomas A. Mustoe, MD, FACS,et al.  Role of platelet‐derived growth factor in wound healing , 1991, Journal of cellular biochemistry.

[5]  S. Badylak,et al.  Small Intestinal Submucosa: Utilization for Repair of Rodent Abdominal Wall Defects , 1995, Annals of plastic surgery.

[6]  T. A. Fritz,et al.  Heparan sulfate primed on β‐D‐xylosides restores binding of basic fibroblast growth factor , 1995, Journal of cellular biochemistry.

[7]  L. Bonewald,et al.  Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein , 1995, The Journal of cell biology.

[8]  S. Wahl,et al.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[10]  C F Fox,et al.  Prospects for application of biotechnology‐derived biomaterials , 1994, Journal of cellular biochemistry.

[11]  S. Badylak,et al.  Biocompatibility of small-intestinal submucosa in urinary tract as augmentation cystoplasty graft and injectable suspension. , 1994, Journal of endourology.

[12]  E. Bell,et al.  Strategy for the selection of scaffolds for tissue engineering. , 1995, Tissue engineering.

[13]  S. Badylak,et al.  Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. , 1996, Tissue engineering.

[14]  J. Dasch,et al.  Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone. , 1992, The Journal of biological chemistry.

[15]  M. Klagsbrun,et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Gregory S. Schultz,et al.  EGF and TGF‐α in wound healing and repair , 1991 .

[17]  K. Miyazono,et al.  Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein , 1994, The Journal of cell biology.

[18]  L A Geddes,et al.  Small intestinal submucosa as a vascular graft: a review. , 1993, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[19]  D. Moscatelli,et al.  Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Stephen F. Badylak,et al.  Small Intestinal Submucosa (SIS): A Biomaterial Conducive to Smart Tissue Remodeling , 1993 .

[21]  P. Dijke,et al.  Growth Factors For Wound Healing , 1989, Bio/Technology.

[22]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[23]  S. Badylak,et al.  Small Intestinal Submucosa as an Intra-Articular Ligamentous Graft Material: A Pilot Study in Dogs , 1994, Phlebologie.

[24]  D. Rifkin,et al.  Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis , 1989, Journal of cellular physiology.

[25]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[26]  C. Parish,et al.  Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: Implications for potentiation of growth factor action by heparin , 1995, Journal of cellular biochemistry.

[27]  Jeffrey A. Hubbell,et al.  Biomaterials in Tissue Engineering , 1995, Bio/Technology.

[28]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[29]  J. Elder,et al.  Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa. , 1989, British Journal of Cancer.

[30]  J. S. Hunt,et al.  Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. , 1995, Placenta.

[31]  J. Howell Current and future trends in wound healing. , 1992, Emergency medicine clinics of North America.

[32]  M J Bissell,et al.  A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. , 1995, Current opinion in cell biology.

[33]  J. Lélias,et al.  High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Nanney,et al.  Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[35]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[36]  I. Yannas,et al.  Applications of ECM analogs in surgery , 1994, Journal of cellular biochemistry.

[37]  M. Sporn,et al.  Transforming Growth Factor‐β , 1990 .

[38]  A. Reddi Symbiosio of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage , 1994, Journal of cellular biochemistry.

[39]  S. Badylak,et al.  The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. , 1995, Journal of biomedical materials research.